Celldex Therapeutics, Inc. (CLDX)
30.15
-0.07
(-0.23%)
USD |
NASDAQ |
May 19, 16:00
30.15
0.00 (0.00%)
After-Hours: 16:06
Celldex Therapeutics Profit Margin (Quarterly) : -524.6K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -675.7% |
| Perspective Therapeutics, Inc. | -34.46K% |
| Myriad Genetics, Inc. | -17.02% |
| Atossa Therapeutics, Inc. | -- |
| AVITA Medical, Inc. | -55.12% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.24% |
| Return on Assets | -44.67% |
| Return on Invested Capital | -48.02% |
| Gross Profit Margin (Quarterly) | -5.59K% |
| Operating Margin (Quarterly) | -562.9K% |
| Return on Net Operating Assets | -788.8% |